drugset / Trial / NCT03943576

Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis

NCT03943576 ↗

Phase 1/2 Completed 25 enrolled Gwo Xi Stem Cell Applied Technology Co., Ltd.
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of the investigators study was to investigate the safety and efficacy of allogeneic ADSCs for the clinical treatment of knee osteoarthritis.

Timeline

Start
2019-12-01
Primary completion
2022-04-27
Completion
2023-03-22

Drugs

EvaluationDrugModalityDoseRoute
Subject GXCPC1 Cell therapy 6.7e+06 cells Other
Subject GXCPC1 Cell therapy 4e+07 cells Other

Indications